In the last years, a variety of potential urinary biomarkers have been proposed for ovarian cancer, including individual proteins (MSL, HE4, CA125, BCL-2), microRNAs (miR-30a-5p, miR-6076) or metabolites (polyamines, succinate) (11). This evidence concerns the gene MUC16 and ovarian carcinoma.